Taiho Pharmaceutical Competitors and Similar CompaniesClear all

Taiho Pharmaceutical's competitors and similar companies include CureVac, PLIVA and Biocon.

	Taiho Pharmaceutical Taiho Pharmaceutical (大鵬薬品) is a company that researches, manufactures, and markets medicines, food supplements, and medical devices.	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.	Biocon Biocon is a company that develops and manufactures biopharmaceutical products.
Founding Date	Founding Date 1963	Founding Date 2000	Founding Date 1921	Founding Date 1978
Type	Type Subsidiary	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Tokyo, JP HQ Oakville, CA Beijing, CN Nagoya, JP Okayama, JP Sendai, JP Tokyo, JP see more	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS	Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more
Employees	Employees 2,1591% decrease	Employees 82517% decrease	Employees 1,685	Employees 16,5612% increase
Financial
Revenue (est.)	Revenue (est.) ¥139.4b (FY, 2022)	Revenue (est.) €535.2m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) ₹167.8b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods €9.7m (FY, 2024)	Cost of goods N/A	Cost of goods ₹56.9b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit €534.4m (FY, 2024)	Gross profit N/A	Gross profit ₹115.8b (FY, 2026)
Net income	Net income ¥5.1b (FY, 2022)	Net income €162.2m (FY, 2024)	Net income N/A	Net income ₹3.7b (FY, 2026)